Angioplasty and Stenting for Stroke Prevention, Good Questions That Need Answers
Neurol 59:664-668, Chaturvedi,S.&Fessler,R., 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Neurology:Then, Now, and in the Future
Arch Neurol 59:1369-1373, McKhann,G.M., 2002
Cessation of Smoking after First-Ever Stroke
Stroke 33:2263-2269, Bak,S.,et al, 2002
AAC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Stroke 33:2337-2341, Pasternak,R.C.,et al, 2002
Improvement of a Patient with a Stuttering on Levetiracetam
Neurol 59:1288, Canevini,M.P.,et al, 2002
High-Dose Thiopental in the Treatment of Refractory Status Epilepticus in Intensive Care Unit
Neurol 59:1249-1251, Parviainen,I.,et al, 2002
Recommendations for the Endovascular Treatment of Intracranial Aneurysms
Stroke 33:2536-2544, Johnston,S.C.,et al, 2002
Migraine--Current Understanding and Treatment
NEJM 346:257-270, Goadsby,P.J.,et al, 2002
Benefit of Atrial Pacing in Sleep Apnea Syndrome
NEJM 346:404-412,390,444, Garrigue,S., et al, 2002
Alcohol Consumption and Risk of Dementia: the Rotterdam Study
Lancet 359:281-286, Ruitenberg,A.,et al, 2002
Poststroke Seizures
Arch Neurol 59:195-202, Silverman,I.E.,et al, 2002
Refractory Status Epilepticus
Arch Neurol 59:205-210,188, Mayer,S.A.,et al, 2002
Quality of Life, Anxiety, and Depression in Patients With an Untreated Intracranial Aneurysm or Arteriovenous Malformation
Stroke 33:440-443, van der Schaaf,I.C.,et al, 2002
Association Between Influenza Vaccination and Reduced Risk of Brain Infarction
Stroke 33:513-518, LavalTe,P.,et al, 2002
Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Infective Endocarditis Resulting from CardioSEAL Closure of a Patent Foramen Ovale
Catheter Cardiovasc Interv 55:217-220, Goldstein,J.A.,et al, 2002
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Low Back Pain
NEJM 344:363-370, Deyo,R.A. &Weinstein,J.N., 2001
Anticipation of Epileptic Seizures from Standard EEG Recordings
Lancet 357:183-188,160, Le Van Quyen,M.,et al, 2001
Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001
Vagal-nerve Stimulation for Epilepsy
Lancet 357:1726-1727, Chadwick,D., 2001
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001
Statins for Stroke Prevention?
Lancet 357:1548-1549, Sandercock,P., 2001
Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001
Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1496-1504, Secondary Progressive Efficacy Clinical Trial of R, 2001
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
Barriers to Acute Stroke Therapy and Stroke Prevention in Mexican Americans
Stroke 32:1360-1364, Morgenstern,L.B.,et al, 2001
Autologous Hematopoietic Stem Cell Transplantation Suppresses Gd-enhanced MRI activity in MS
Neurol 57:62-68, Mancardi,G.L.,et al, 2001
Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects
JAMA 285:2981-2986,3022, Honein,M.A.,et al, 2001
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Eiplepsy
NEJM 345:311-318,365, Wiebe,S.,et al, 2001
Is Carbamazepine Teratogenic? A Prospective Controlled Study of 210 Pregnancies
Neurol 57:321-324, Diav-Citrin,O.,et al, 2001
Dietary Potassium Intake and Risk of Stroke in US Men and Women
Stroke 32:1473-1480, Bazzano,L.A.,et al, 2001
Continuous EEG Monitoring and Midazolam Infusion for Refractory Nonconvulsive Status Epilepticus
Neurol 57:1036-1042, Claasen,J.,et al, 2001
Serial EEG During Human Status Epilepticus
Neurol 57:1175-1183, Garzon,E.,et al, 2001
High-grade Carotid Stenosis Detected Before General Surgery: Is Endarterectomy Indicated?
Neurol 57:1328-1330, Evans,B.A. &Wijdicks,E.F.M., 2001
Dysgeusia in Epileptic Patients Treated with Lamotrigine: Report of Three Cases
Neurol 57:1521, Avoni,P.,et al, 2001
A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke
NEJM 345:1243-1249, Viscoli,C.M.,et al, 2001
Extracranial Carotid Stenosis
NEJM 345:1113-1118, Sacco,R., 2001
Randomised Trial of a Perindopril-based Blood-pressure-lowering Regimen Among 6105 Individuals with Previous Stroke or Transient Ischaemic Attack
Lancet 358:1033-1041,1026, PROGRESS Collaborative Group, 2001
Lamotrigine in the Treatment of SUNCT Syndrome
Neurol 57:1723-1725, D'Andrea,G.,et al, 2001
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
NEJM 345:1515-1521,1567, in 'T Veld,B.A.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001